Pathogenesis of ANCA-associated vasculitis: An update

Autoimmunity Reviews

Volumn 15, Issue 7, 2016, Pages 704-713

  Jarrot, Pierre André ^a,b   Kaplanski, Gilles ^a,b  

^a HÔPITAL DE LA CONCEPTION   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Antineutrophil cytoplasmic antibody associated vasculitis; Antineutrophil cytoplasmic autoantibodies; Immune response; Neutrophil extracellular traps

Indexed keywords

AUTOANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADAPTIVE IMMUNITY; ANCA ASSOCIATED VASCULITIS; AUTOIMMUNITY; B LYMPHOCYTE; COMPLEMENT ALTERNATIVE PATHWAY; EXTRACELLULAR TRAP; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MONOCYTE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PATHOGENICITY; REVIEW; T LYMPHOCYTE; ANIMAL; DISEASE MODEL; IMMUNOLOGY; PATHOLOGY;

ANIMALS; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; HUMANS;

EID: 84966801124     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2016.03.007     Document Type: Review

References (133)

1. Jennette J.C., Falk R.J., Bacon P.A., Basu N., Cid M.C., Ferrario F., et al. 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013, 65:1-11.
2. Comarmond C., Cacoub P. Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment. Autoimmun Rev 2014, 13:1121-1125.
3. Greco A., Rizzo M.I., De Virgilio A., Gallo A., Fusconi M., Ruoppolo G., et al. Churg-Strauss syndrome. Autoimmun Rev 2015, 14:341-348.
4. Greco A., De Virgilio A., Rizzo M.I., Gallo A., Magliulo G., Fusconi M., et al. Microscopic polyangiitis: advances in diagnostic and therapeutic approaches. Autoimmun Rev 2015, 14:837-844.
5. Falk R.J., Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988, 318:1651-1657.
6. Jenne D.E., Tschopp J., Ludemann J., Utecht B., Gross W.L. Wegener's autoantigen decoded. Nature 1990, 346:520.
7. Jennette J.C., Hoidal J.R., Falk R.J. Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood 1990, 75:2263-2264.
8. Falk R.J., Terrell R.S., Charles L.A., Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 1990, 87:4115-4119.
9. Nolan S.L., Kalia N., Nash G.B., Kamel D., Heeringa P., Savage C.O. Mechanisms of ANCA-mediated leukocyte-endothelial cell interactions in vivo. J Am Soc Nephrol 2008, 19:973-984.
10. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., et al. Neutrophil extracellular traps kill bacteria. Science 2004, 303:1532-1535.
11. Saffarzadeh M., Juenemann C., Queisser M.A., Lochnit G., Barreto G., Galuska S.P., et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One 2012, 7.
12. Sangaletti S., Tripodo C., Chiodoni C., Guarnotta C., Cappetti B., Casalini P., et al. Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity. Blood 2012, 120:3007-3018.
13. Morgan M.D., Day C.J., Piper K.P., Khan N., Harper L., Moss P.A., et al. Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells. Immunology 2010, 130:64-73.
14. Dumoitier N., Terrier B., London J., Lofek S., Mouthon L. Implication of B lymphocytes in the pathogenesis of ANCA-associated vasculitides. Autoimmun Rev 2015, 14:996-1004.
15. Schreiber A., Xiao H., Jennette J.C., Schneider W., Luft F.C., Kettritz R. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J Am Soc Nephrol 2009, 20:289-298.
16. Davies D.J., Moran J.E., Niall J.F., Ryan G.B. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?. Br Med J (Clin Res Ed) 1982, 285:606.
17. van der Woude F.J. Anticytoplasmic antibodies in Wegener's granulomatosis. Lancet 1985, 2:48.
18. Radford D.J., Luu N.T., Hewins P., Nash G.B., Savage C.O. Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells. Arthritis Rheum 2001, 44:2851-2861.
19. Schlieben D.J., Korbet S.M., Kimura R.E., Schwartz M.M., Lewis E.J. Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs. Am J Kidney Dis 2005, 45:758-761.
20. Xiao H., Heeringa P., Hu P., Liu Z., Zhao M., Aratani Y., et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002, 110:955-963.
21. Xiao H., Heeringa P., Liu Z., Huugen D., Hu P., Maeda N., et al. The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol 2005, 167:39-45.
22. Korkmaz B., Jenne D.E., Gauthier F. Relevance of the mouse model as a therapeutic approach for neutrophil proteinase 3-associated human diseases. Int Immunopharmacol 2013, 17:1198-1205.
23. Witko-Sarsat V., Lesavre P., Lopez S., Bessou G., Hieblot C., Prum B., et al. A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J Am Soc Nephrol 1999, 10:1224-1233.
24. Wiesner O., Litwiller R.D., Hummel A.M., Viss M.A., McDonald C.J., Jenne D.E., et al. Differences between human proteinase 3 and neutrophil elastase and their murine homologues are relevant for murine model experiments. FEBS Lett 2005, 579:5305-5312.
25. Primo V.C., Marusic S., Franklin C.C., Goldmann W.H., Achaval C.G., Smith R.N., et al. Anti-PR3 immune responses induce segmental and necrotizing glomerulonephritis. Clin Exp Immunol 2010, 159:327-337.
26. Little M.A., Al-Ani B., Ren S., Al-Nuaimi H., Leite M., Alpers C.E., et al. Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system. PLoS One 2012, 7.
27. Lyons P.A., Rayner T.F., Trivedi S., Holle J.U., Watts R.A., Jayne D.R., et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 2012, 367:214-223.
28. Xie G., Roshandel D., Sherva R., Monach P.A., Lu E.Y., Kung T., et al. Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis. Arthritis Rheum 2013, 65:2457-2468.
29. Cui Z., Zhao M.H., Segelmark M., Hellmark T. Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals. Kidney Int 2010, 78:590-597.
30. Xu P.C., Cui Z., Chen M., Hellmark T., Zhao M.H. Comparison of characteristics of natural autoantibodies against myeloperoxidase and anti-myeloperoxidase autoantibodies from patients with microscopic polyangiitis. Rheumatology (Oxford) 2011, 50:1236-1243.
31. Savige J., Dimech W., Fritzler M., Goeken J., Hagen E.C., Jennette J.C., et al. Addendum to the international consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. Am J Clin Pathol 2003, 120:312-318.
32. Ooi C.J., Lim B.L., Cheong W.K., Ling A.E., Ng H.S. Antineutrophil cytoplasmic antibodies (ANCAs) in patients with inflammatory bowel disease show no correlation with proteinase 3, lactoferrin, myeloperoxidase, elastase, cathepsin G and lysozyme: a Singapore study. Ann Acad Med Singapore 2000, 29:704-707.
33. Chin H.J., Ahn C., Lim C.S., Chung H.K., Lee J.G., Song Y.W., et al. Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis. Am J Nephrol 2000, 20:57-63.
34. Roth A.J., Ooi J.D., Hess J.J., van Timmeren M.M., Berg E.A., Poulton C.E., et al. Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. J Clin Invest 2013, 123:1773-1783.
35. Gou S.J., Xu P.C., Chen M., Zhao M.H. Epitope analysis of anti-myeloperoxidase antibodies in patients with ANCA-associated vasculitis. PLoS One 2013, 8.
36. Agmon-Levin N., Blank M., Paz Z., Shoenfeld Y. Molecular mimicry in systemic lupus erythematosus. Lupus 2009, 18:1181-1185.
37. Heal J.R., Roberts G.W., Raynes J.G., Bhakoo A., Miller A.D. Specific interactions between sense and complementary peptides: the basis for the proteomic code. Chembiochem 2002, 3:136-151.
38. Miller A.D. Sense-antisense (complementary) peptide interactions and the proteomic code; potential opportunities in biology and pharmaceutical science. Expert Opin Biol Ther 2015, 15:245-267.
39. Pendergraft W.F., Preston G.A., Shah R.R., Tropsha A., Carter C.W., Jennette J.C., et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 2004, 10:72-79.
40. Pudifin D.J., Duursma J., Gathiram V., Jackson T.F. Invasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibody. Clin Exp Immunol 1994, 97:48-51.
41. Popa E.R., Stegeman C.A., Kallenberg C.G., Tervaert J.W. Staphylococcus aureus and Wegener's granulomatosis. Arthritis Res 2002, 4:77-79.
42. Tadema H., Kallenberg C.G., Stegeman C.A., Heeringa P. Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA-associated vasculitis. PLoS One 2011, 6.
43. Kain R., Exner M., Brandes R., Ziebermayr R., Cunningham D., Alderson C.A., et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 2008, 14:1088-1096.
44. Roth A.J., Brown M.C., Smith R.N., Badhwar A.K., Parente O., Chung H., et al. Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis. J Am Soc Nephrol 2012, 23:545-555.
45. Takeda K., Akira S. Toll-like receptors in innate immunity. Int Immunol 2005, 17:1-14.
46. Tadema H., Heeringa P., Kallenberg C.G. Bacterial infections in Wegener's granulomatosis: mechanisms potentially involved in autoimmune pathogenesis. Curr Opin Rheumatol 2011, 23:366-371.
47. Holle J.U., Windmoller M., Lange C., Gross W.L., Herlyn K., Csernok E. Toll-like receptor TLR2 and TLR9 ligation triggers neutrophil activation in granulomatosis with polyangiitis. Rheumatology (Oxford) 2013, 52:1183-1189.
48. Husmann C.A., Holle J.U., Moosig F., Mueller S., Wilde B., Cohen Tervaert J.W., et al. Genetics of toll like receptor 9 in ANCA associated vasculitides. Ann Rheum Dis 2014, 73:890-896.
49. Radic M., Martinovic Kaliterna D., Radic J. Drug-induced vasculitis: a clinical and pathological review. Neth J Med 2012, 70:12-17.
50. De la Cruz-Hernandez E., Perez-Plasencia C., Perez-Cardenas E., Gonzalez-Fierro A., Trejo-Becerril C., Chavez-Blanco A., et al. Transcriptional changes induced by epigenetic therapy with hydralazine and magnesium valproate in cervical carcinoma. Oncol Rep 2011, 25:399-407.
51. Pendergraft W.F., Niles J.L. Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. Curr Opin Rheumatol 2014, 26:42-49.
52. Waldhauser L., Uetrecht J. Antibodies to myeloperoxidase in propylthiouracil-induced autoimmune disease in the cat. Toxicology 1996, 114:155-162.
53. Bjorck S., Brundin C., Lorinc E., Lynch K.F., Agardh D. Screening detects a high proportion of celiac disease in young HLA-genotyped children. J Pediatr Gastroenterol Nutr 2010, 50:49-53.
54. Sollid L.M., Pos W., Wucherpfennig K.W. Molecular mechanisms for contribution of MHC molecules to autoimmune diseases. Curr Opin Immunol 2014, 31:24-30.
55. Reumaux D., Hordijk P.L., Duthilleul P., Roos D. Priming by tumor necrosis factor-alpha of human neutrophil NADPH-oxidase activity induced by anti-proteinase-3 or anti-myeloperoxidase antibodies. J Leukoc Biol 2006, 80:1424-1433.
56. Aida Y., Pabst M.J. Priming of neutrophils by lipopolysaccharide for enhanced release of superoxide. Requirement for plasma but not for tumor necrosis factor-alpha. J Immunol 1990, 145:3017-3025.
57. Hewins P., Morgan M.D., Holden N., Neil D., Williams J.M., Savage C.O., et al. IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis. Kidney Int 2006, 69:605-615.
58. Wang C., Wang H., Chang D.Y., Hao J., Zhao M.H., Chen M. High mobility group box 1 contributes to anti-neutrophil cytoplasmic antibody-induced neutrophils activation through receptor for advanced glycation end products (RAGE) and Toll-like receptor 4. Arthritis Res Ther 2015, 17:64.
59. Reumaux D., Vossebeld P.J., Roos D., Verhoeven A.J. Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood 1995, 86:3189-3195.
60. Mavropoulos A., Orfanidou T., Liaskos C., Smyk D.S., Billinis C., Blank M., et al. p38 mitogen-activated protein kinase (p38 MAPK)-mediated autoimmunity: lessons to learn from ANCA vasculitis and pemphigus vulgaris. Autoimmun Rev 2013, 12:580-590.
61. Hao J., Meng L.Q., Xu P.C., Chen M., Zhao M.H. p38MAPK, ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation. PLoS One 2012, 7.
62. van Rossum A.P., Rarok A.A., Huitema M.G., Fassina G., Limburg P.C., Kallenberg C.G. Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti-PR3 antibodies. J Leukoc Biol 2004, 76:1162-1170.
63. Rarok A.A., Stegeman C.A., Limburg P.C., Kallenberg C.G. Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis. J Am Soc Nephrol 2002, 13:2232-2238.
64. Schreiber A., Luft F.C., Kettritz R. Membrane proteinase 3 expression and ANCA-induced neutrophil activation. Kidney Int 2004, 65:2172-2183.
65. Jerke U., Rolle S., Dittmar G., Bayat B., Santoso S., Sporbert A., et al. Complement receptor Mac-1 is an adaptor for NB1 (CD177)-mediated PR3-ANCA neutrophil activation. J Biol Chem 2011, 286:7070-7081.
66. Bayat B., Werth S., Sachs U.J., Newman D.K., Newman P.J., Santoso S. Neutrophil transmigration mediated by the neutrophil-specific antigen CD177 is influenced by the endothelial S536N dimorphism of platelet endothelial cell adhesion molecule-1. J Immunol 2010, 184:3889-3896.
67. Kuckleburg C.J., Tilkens S.B., Santoso S., Newman P.J. Proteinase 3 contributes to transendothelial migration of NB1-positive neutrophils. J Immunol 2012, 188:2419-2426.
68. Hu N., Westra J., Huitema M.G., Bijl M., Brouwer E., Stegeman C.A., et al. Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils. Arthritis Rheum 2009, 60:1548-1557.
69. Ciavatta D.J., Yang J., Preston G.A., Badhwar A.K., Xiao H., Hewins P., et al. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. J Clin Invest 2010, 120:3209-3219.
70. McInnis E.A., Badhwar A.K., Muthigi A., Lardinois O.M., Allred S.C., Yang J., et al. Dysregulation of autoantigen genes in ANCA-associated vasculitis involves alternative transcripts and new protein synthesis. J Am Soc Nephrol 2015, 26:390-399.
71. Porges A.J., Redecha P.B., Kimberly W.T., Csernok E., Gross W.L., Kimberly R.P. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J Immunol 1994, 153:1271-1280.
72. Kocher M., Siegel M.E., Edberg J.C., Kimberly R.P. Cross-linking of Fc gamma receptor IIa and Fc gamma receptor IIIb induces different proadhesive phenotypes on human neutrophils. J Immunol 1997, 159:3940-3948.
73. Williams J.M., Ben-Smith A., Hewins P., Dove S.K., Hughes P., McEwan R., et al. Activation of the G(i) heterotrimeric G protein by ANCA IgG F(ab')2 fragments is necessary but not sufficient to stimulate the recruitment of those downstream mediators used by intact ANCA IgG. J Am Soc Nephrol 2003, 14:661-669.
74. Ooi J.D., Gan P.Y., Chen T., Eggenhuizen P.J., Chang J., Alikhan M.A., et al. FcgammaRIIB regulates T-cell autoreactivity, ANCA production, and neutrophil activation to suppress anti-myeloperoxidase glomerulonephritis. Kidney Int 2014, 86:1140-1149.
75. van Timmeren M.M., van der Veen B.S., Stegeman C.A., Petersen A.H., Hellmark T., Collin M., et al. IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis. J Am Soc Nephrol 2010, 21:1103-1114.
76. Schreiber A., Pham C.T., Hu Y., Schneider W., Luft F.C., Kettritz R. Neutrophil serine proteases promote IL-1beta generation and injury in necrotizing crescentic glomerulonephritis. J Am Soc Nephrol 2012, 23:470-482.
77. Johnson R.J., Couser W.G., Chi E.Y., Adler S., Klebanoff S.J. New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest 1987, 79:1379-1387.
78. Schreiber A., Luft F.C., Kettritz R. Phagocyte NADPH oxidase restrains the inflammasome in ANCA-induced GN. J Am Soc Nephrol 2015, 26:411-424.
79. Millet A., Martin K.R., Bonnefoy F., Saas P., Mocek J., Alkan M., et al. Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis. J Clin Invest 2015, 125:4107-4121.
80. Brachemi S., Mambole A., Fakhouri F., Mouthon L., Guillevin L., Lesavre P., et al. Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti proteinase 3 antibodies. J Am Soc Nephrol 2007, 18:2330-2339.
81. Rahman A., Fazal F. Hug tightly and say goodbye: role of endothelial ICAM-1 in leukocyte transmigration. Antioxid Redox Signal 2009, 11:823-839.
82. Savage C.O., Gaskin G., Pusey C.D., Pearson J.D. Anti-neutrophil cytoplasm antibodies can recognize vascular endothelial cell-bound anti-neutrophil cytoplasm antibody-associated autoantigens. Exp Nephrol 1993, 1:190-195.
83. Weidner S., Carl M., Riess R., Rupprecht H.D. Histologic analysis of renal leukocyte infiltration in antineutrophil cytoplasmic antibody-associated vasculitis: importance of monocyte and neutrophil infiltration in tissue damage. Arthritis Rheum 2004, 50:3651-3657.
84. Tarzi R.M., Liu J., Schneiter S., Hill N.R., Page T.H., Cook H.T., et al. CD14 expression is increased on monocytes in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis and correlates with the expression of ANCA autoantigens. Clin Exp Immunol 2015, 181:65-75.
85. Weidner S., Neupert W., Goppelt-Struebe M., Rupprecht H.D. Antineutrophil cytoplasmic antibodies induce human monocytes to produce oxygen radicals in vitro. Arthritis Rheum 2001, 44:1698-1706.
86. O'Brien E.C., Abdulahad W.H., Rutgers A., Huitema M.G., O'Reilly V.P., Coughlan A.M., et al. Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1beta secretion in response to anti-MPO antibodies. Sci Rep 2015, 5:11888.
87. Pinegin B., Vorobjeva N., Pinegin V. Neutrophil extracellular traps and their role in the development of chronic inflammation and autoimmunity. Autoimmun Rev 2015, 14:633-640.
88. Kessenbrock K., Krumbholz M., Schonermarck U., Back W., Gross W.L., Werb Z., et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 2009, 15:623-625.
89. Nakazawa D., Tomaru U., Suzuki A., Masuda S., Hasegawa R., Kobayashi T., et al. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2012, 64:3779-3787.
90. Nakazawa D., Shida H., Tomaru U., Yoshida M., Nishio S., Atsumi T., et al. Enhanced formation and disordered regulation of NETs in myeloperoxidase-ANCA-associated microscopic polyangiitis. J Am Soc Nephrol 2014, 25:990-997.
91. Fuchs T.A., Brill A., Duerschmied D., Schatzberg D., Monestier M., Myers D.D., et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A 2010, 107:15880-15885.
92. von Bruhl M.L., Stark K., Steinhart A., Chandraratne S., Konrad I., Lorenz M., et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012, 209:819-835.
93. Nakazawa D., Tomaru U., Yamamoto C., Jodo S., Ishizu A. Abundant neutrophil extracellular traps in thrombus of patient with microscopic polyangiitis. Front Immunol 2012, 3:333.
94. Voswinkel J., Mueller A., Kraemer J.A., Lamprecht P., Herlyn K., Holl-Ulrich K., et al. B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions. Ann Rheum Dis 2006, 65:859-864.
95. Stone J.H., Merkel P.A., Spiera R., Seo P., Langford C.A., Hoffman G.S., et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010, 363:221-232.
96. Guillevin L., Pagnoux C., Karras A., Khouatra C., Aumaitre O., Cohen P., et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med 2014, 371:1771-1780.
97. Popa E.R., Stegeman C.A., Bos N.A., Kallenberg C.G., Tervaert J.W. Differential B- and T-cell activation in Wegener's granulomatosis. J Allergy Clin Immunol 1999, 103:885-894.
98. Culton D.A., Nicholas M.W., Bunch D.O., Zhen Q.L., Kepler T.B., Dooley M.A., et al. Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. J Clin Immunol 2007, 27:53-68.
99. Dorner T., Giesecke C., Lipsky P.E. Mechanisms of B cell autoimmunity in SLE. Arthritis Res Ther 2011, 13:243.
100. Mauri C. Regulation of immunity and autoimmunity by B cells. Curr Opin Immunol 2010, 22:761-767.
101. Flores-Borja F., Bosma A., Ng D., Reddy V., Ehrenstein M.R., Isenberg D.A., et al. CD19 + CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med 2013, 5:173ra23.
102. Klinker M.W., Lundy S.K. Multiple mechanisms of immune suppression by B lymphocytes. Mol Med 2012, 18:123-137.
103. Todd S.K., Pepper R.J., Draibe J., Tanna A., Pusey C.D., Mauri C., et al. Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford) 2014, 53:1693-1703.
104. Lepse N., Abdulahad W.H., Rutgers A., Kallenberg C.G., Stegeman C.A., Heeringa P. Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission. Rheumatology (Oxford) 2014, 53:1683-1692.
105. Wilde B., Thewissen M., Damoiseaux J., Knippenberg S., Hilhorst M., van Paassen P., et al. Regulatory B cells in ANCA-associated vasculitis. Ann Rheum Dis 2013, 72:1416-1419.
106. Unizony S., Lim N., Phippard D.J., Carey V.J., Miloslavsky E.M., Tchao N.K., et al. Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol 2015, 67:535-544.
107. Muller A., Trabandt A., Gloeckner-Hofmann K., Seitzer U., Csernok E., Schonermarck U., et al. Localized Wegener's granulomatosis: predominance of CD26 and IFN-gamma expression. J Pathol 2000, 192:113-120.
108. Sanders J.S., Huitma M.G., Kallenberg C.G., Stegeman C.A. Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse. Ann Rheum Dis 2006, 65:1484-1489.
109. Schonermarck U., Csernok E., Trabandt A., Hansen H., Gross W.L. Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides. Clin Exp Rheumatol 2000, 18:457-463.
110. Wang G., Hansen H., Tatsis E., Csernok E., Lemke H., Gross W.L. High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis. Am J Med 1997, 102:517-523.
111. Ooi J.D., Kitching A.R., Holdsworth S.R. Review: T helper 17 cells: their role in glomerulonephritis. Nephrology (Carlton) 2010, 15:513-521.
112. Hoshino A., Nagao T., Nagi-Miura N., Ohno N., Yasuhara M., Yamamoto K., et al. MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner. J Autoimmun 2008, 31:79-89.
113. Gan P.Y., Steinmetz O.M., Tan D.S., O'Sullivan K.M., Ooi J.D., Iwakura Y., et al. Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis. J Am Soc Nephrol 2010, 21:925-931.
114. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4 + CD25+ regulatory T cells. Nat Immunol 2003, 4:330-336.
115. Abdulahad W.H., Stegeman C.A., van der Geld Y.M., Doornbos-van der Meer B., Limburg P.C., Kallenberg C.G. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission. Arthritis Rheum 2007, 56:2080-2091.
116. Rimbert M., Hamidou M., Braudeau C., Puechal X., Teixeira L., Caillon H., et al. Decreased numbers of blood dendritic cells and defective function of regulatory T cells in antineutrophil cytoplasmic antibody-associated vasculitis. PLoS One 2011, 6.
117. Free M.E., Bunch D.O., McGregor J.A., Jones B.E., Berg E.A., Hogan S.L., et al. Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell population. Arthritis Rheum 2013, 65:1922-1933.
118. Abdulahad W.H., Kallenberg C.G., Limburg P.C., Stegeman C.A. Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2009, 60:2830-2838.
119. Scapini P., Bazzoni F., Cassatella M.A. Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils. Immunol Lett 2008, 116:1-6.
120. Krumbholz M., Specks U., Wick M., Kalled S.L., Jenne D., Meinl E. BAFF is elevated in serum of patients with Wegener's granulomatosis. J Autoimmun 2005, 25:298-302.
121. Nagai M., Hirayama K., Ebihara I., Shimohata H., Kobayashi M., Koyama A. Serum levels of BAFF and APRIL in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis: association with disease activity. Nephron Clin Pract 2011, 118:c339-c345.
122. Xin G., Chen M., Su Y., Xu L.X., Zhao M.H., Li K.S. Serum B-cell activating factor in myeloperoxiase-antineutrophil cytoplasmic antibodies-associated vasculitis. Am J Med Sci 2014, 348:25-29.
123. Lenert A., Lenert P. Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents. Drug Des Devel Ther 2015, 9:333-347.
124. Rahmattulla C., Bruijn J.A., Bajema I.M. Histopathological classification of antineutrophil cytoplasmic antibody-associated glomerulonephritis: an update. Curr Opin Nephrol Hypertens 2014, 23:224-231.
125. Lutalo P.M., D'Cruz D.P. Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener's granulomatosis). J Autoimmun 2014, 48-49:94-98.
126. Haas M., Eustace J.A. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int 2004, 65:2145-2152.
127. Xiao H., Schreiber A., Heeringa P., Falk R.J., Jennette J.C. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 2007, 170:52-64.
128. Huugen D., Xiao H., van Esch A., Falk R.J., Peutz-Kootstra C.J., Buurman W.A., et al. Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha. Am J Pathol 2005, 167:47-58.
129. Xiao H., Dairaghi D.J., Powers J.P., Ertl L.S., Baumgart T., Wang Y., et al. C5a receptor (CD88) blockade protects against MPO-ANCA GN. J Am Soc Nephrol 2014, 25:225-231.
130. Gou S.J., Yuan J., Chen M., Yu F., Zhao M.H. Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. Kidney Int 2013, 83:129-137.
131. Chen S.F., Wang F.M., Li Z.Y., Yu F., Zhao M.H., Chen M. Plasma complement factor H is associated with disease activity of patients with ANCA-associated vasculitis. Arthritis Res Ther 2015, 17:129.
132. Camous L., Roumenina L., Bigot S., Brachemi S., Fremeaux-Bacchi V., Lesavre P., et al. Complement alternative pathway acts as a positive feedback amplification of neutrophil activation. Blood 2011, 117:1340-1349.
133. Wang H., Wang C., Zhao M.H., Chen M. Neutrophil extracellular traps can activate alternative complement pathways. Clin Exp Immunol 2015, 181:518-527.